Role of MicroRNA-1 in human cancer and its therapeutic potentials

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Han, Chao ^a   Yu, Zujiang ^a   Duan, Zhenfeng ^b   Kan, Quancheng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 1; MICRORNA; MIRN1 MICRORNA, HUMAN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; DIGESTIVE SYSTEM CANCER; GENE EXPRESSION; GENE FUNCTION; HEAD AND NECK CANCER; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MODULATION; NUCLEOTIDE SEQUENCE; REVIEW; SARCOMA; UROGENITAL TRACT CANCER; APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; NEOPLASM; PATHOLOGY;

APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASMS;

EID: 84902205097     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/428371     Document Type: Review

References (83)

1. Bartel D. P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004 116 2 281 297 2-s2.0-0347444723 10.1016/S0092-8674(04)00045-5 (Pubitemid 38167318)
2. Hwang H.-W., Mendell J. T., MicroRNAs in cell proliferation, cell death, and tumorigenesis. British Journal of Cancer 2006 94 6 776 780 2-s2.0-33645321647 10.1038/sj.bjc.6603023
3. Croce C. M., Causes and consequences of microRNA dysregulation in cancer. Nature Reviews Genetics 2009 10 10 704 714 2-s2.0-70349320158 10.1038/nrg2634
4. Alam M. M., O'Neill L. A., MicroRNAs and the resolution phase of inflammation in macrophages. European Journal of Immunology 2011 41 9 2482 2485 2-s2.0-80052158908 10.1002/eji.201141740
5. Lee R. C., Feinbaum R. L., Ambros V., The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 75 5 843 854 2-s2.0-0027751663 10.1016/0092-8674(93)90529-Y (Pubitemid 24014542)
6. Kim V. N., MicroRNA biogenesis: coordinated cropping and dicing. Nature Reviews Molecular Cell Biology 2005 6 5 376 385 2-s2.0-18344369543 10.1038/nrm1644 (Pubitemid 40637855)
7. Chang T.-C., Mendell J. T., MicroRNAs in vertebrate physiology and human disease. Annual Review of Genomics and Human Genetics 2007 8 215 239 2-s2.0-35348821616 10.1146/annurev.genom.8.080706.092351
8. Zhang B., Wang Q., Pan X., MicroRNAs and their regulatory roles in animals and plants. Journal of Cellular Physiology 2007 210 2 279 289 2-s2.0-33845601726 10.1002/jcp.20869 (Pubitemid 44956872)
9. Ryan B. M., Robles A. I., Harris C. C., Genetic variation in microRNA networks: the implications for cancer research. Nature Reviews Cancer 2010 10 6 389 402 2-s2.0-77952918274 10.1038/nrc2867
10. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
11. He L., Hannon G. J., MicroRNAs: small RNAs with a big role in gene regulation. Nature Reviews Genetics 2004 5 7 522 531 2-s2.0-3042767202 10.1038/nrg1379 (Pubitemid 38868508)
12. Liu C., Kelnar K., Vlassov A. V., Brown D., Wang J., Tang D. G., Distinct microRNA expression profiles in prostate cancer stem/progenitor cells and tumor-suppressive functions of let-7. Cancer Research 2012 72 13 3393 3404 10.1158/0008-5472.CAN-11-3864
13. Duan Z., Choy E., Harmon D., Liu X., Susa M., Mankin H., Hornicek F., MicroRNA-199a-3p is downregulated in human osteosarcoma and regulates cell proliferation and migration. Molecular Cancer Therapeutics 2011 10 8 1337 1345 2-s2.0-80051587553 10.1158/1535-7163.MCT-11-0096
14. Duan Z., Choy E., Petur Nielsen G., Rosenberg A., Iafrate J., Yang C., Schwab J., Mankin H., Xavier R., Hornicek F. J., Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in met expression. Journal of Orthopaedic Research 2010 28 6 746 752 2-s2.0-77951491894 10.1002/jor.21055
15. Ratert N., Meyer H. A., Jung M., Mollenkopf H. J., Wagner I., Miller K., Kilic E., Erbersdobler A., Weikert S., Jung K., Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS ONE 2012 7 6 e39309
16. Lang M.-F., Yang S., Zhao C., Sun G., Murai K., Wu X., Wang J., Gao H., Brown C. E., Liu X., Zhou J., Peng L., Rossi J. J., Shi Y., Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells. PLoS ONE 2012 7 4 2-s2.0-84860448293 10.1371/journal.pone.0036248 e36248
17. Akao Y., Nakagawa Y., Hirata I., Iio A., Itoh T., Kojima K., Nakashima R., Kitade Y., Naoe T., Role of anti-oncomirs miR-143 and-145 in human colorectal tumors. Cancer Gene Therapy 2010 17 6 398 408 2-s2.0-77952550515 10.1038/cgt.2009.88
18. Johnson S. M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K. L., Brown D., Slack F. J., RAS is regulated by the let-7 microRNA family. Cell 2005 120 5 635 647 2-s2.0-20044395613 10.1016/j.cell.2005.01.014 (Pubitemid 40343076)
19. Le M. T. N., Teh. C., Shyh-Chang N., Xie H., Zhou B., Korzh V., Lodish H. F., Lim B., MicroRNA-125b is a novel negative regulator of p53. Genes & Development 2009 23 7 862 876 2-s2.0-64349101658 10.1101/gad.1767609
20. Zhang Y., Gao J.-S., Tang X., Tucker L. D., Quesenberry P., Rigoutsos I., Ramratnam B., MicroRNA 125a and its regulation of the p53 tumor suppressor gene. FEBS Letters 2009 583 22 3725 3730 2-s2.0-72049115805 10.1016/j.febslet. 2009.10.002
21. Garzon R., Marcucci G., Croce C. M., Targeting microRNAs in cancer: rationale, strategies and challenges. Nature Reviews Drug Discovery 2010 9 10 775 789 2-s2.0-77957361864 10.1038/nrd3179
22. Bader A. G., Brown D., Winkler M., The promise of microRNA replacement therapy. Cancer Research 2010 70 18 7027 7030 2-s2.0-77956901498 10.1158/0008-5472.CAN-10-2010
23. Nakajima N., Takahashi T., Kitamura R., Isodono K., Asada S., Ueyama T., Matsubara H., Oh H., MicroRNA-1 facilitates skeletal myogenic differentiation without affecting osteoblastic and adipogenic differentiation. Biochemical and Biophysical Research Communications 2006 350 4 1006 1012 2-s2.0-33750035175 10.1016/j.bbrc.2006.09.153 (Pubitemid 44584193)
24. Gagan J., Dey B. K., Layer R., Yan Z., Dutta A., Notch3 and Mef2c are mutually antagonistic via Mkp1 and miR-1/206 in differentiating myoblasts. The Journal of Biological Chemistry 2012 10.1074/jbc.M112.378414
25. Mishima Y., Stahlhut C., Giraldez A. J., miR-1-2 Gets to the heart of the matter. Cell 2007 129 2 247 249 2-s2.0-34147165721 10.1016/j.cell.2007.04.008 (Pubitemid 46574984)
26. Zhao Y., Ransom J. F., Li A., Vedantham V., von Drehle M., Muth A. N., Tsuchihashi T., McManus M. T., Schwartz R. J., Srivastava D., Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 2007 129 2 303 317 2-s2.0-34147153781 10.1016/j.cell.2007.03.030 (Pubitemid 46574975)
27. Long G., Wang F., Duan Q., Chen F., Yang S., Gong W., Wang Y., Chen C., Wang D. W., Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction. International Journal of Biological Sciences 2012 8 6 811 818 10.7150/ijbs.4439
28. Belevych A. E., Sansom S. E., Terentyeva R., Ho H.-T., Nishijima Y., Martin M. M., Jindal H. K., Rochira J. A., Kunitomo Y., Abdellatif M., Carnes C. A., Elton T. S., Györke S., Terentyev D., MicroRNA-1 and -133 increase arrhythmogenesis in heart failure by dissociating phosphatase activity from RyR2 complex. PLoS ONE 2011 6 12 2-s2.0-82755165053 10.1371/journal.pone.0028324 e28324
29. Kumarswamy R., Lyon A. R., Volkmann I., Mills A. M., Bretthauer J., Pahuja A., Geers-Knrr C., Kraft T., Hajjar R. J., MacLeod K. T., Harding S. E., Thum T., SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. European Heart Journal 2012 33 9 1067 1075 2-s2.0-84860623522 10.1093/eurheartj/ehs043
30. Boštjančič E., Zidar N., Štajer D., Glavač D., MicroRNAs miR-1, miR-133a, miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology 2010 115 3 163 169 2-s2.0-72149133679 10.1159/000268088
31. Lewis A., Riddoch-Contreras J., Natanek S. A., Donaldson A., Man W. D.-C., Moxham J., Hopkinson N. S., Polkey M. I., Kemp P. R., Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 2012 67 1 26 34 2-s2.0-84855201605 10.1136/thoraxjnl-2011-200309
32. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA Cancer Journal for Clinicians 2012 62 1 10 29 2-s2.0-84855792427 10.3322/caac.20138
33. Melkamu T., Zhang X., Tan J., Zeng Y., Kassie F., Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol. Carcinogenesis 2010 31 2 252 258 2-s2.0-77649196575 10.1093/carcin/bgp208
34. Nasser M. W., Datta J., Nuovo G., Kutay H., Motiwala T., Majumder S., Wang B., Suster S., Jacob S. T., Ghoshal K., Down-regulation of micro-RNA-1 (miR-1) in lung cancer: suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. The Journal of Biological Chemistry 2008 283 48 33394 33405 2-s2.0-57749089758 10.1074/jbc.M804788200
35. Zhao Q., Zhang B., Shao Y., Chen L., Wang X., Zhang Z., Shu Y., Guo R., Correlation between the expression levels of miR-1 and PIK3CA in non-small-cell lung cancer and their relationship with clinical characteristics and prognosis. Future Oncology 2014 10 1 49 57 10.2217/fon.13.242
36. Yu Q. Q., Wu H., Huang X., Shen H., Shu Y. Q., Zhang B., Xiang C. C., Yu S. M., Guo R. H., Chen L., miR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells. Biomedicine & Pharmacotherapy 2014 68 2 155 161 10.1016/j.biopha.2014.01.005
37. Tominaga E., Yuasa K., Shimazaki S., Hijikata T., MicroRNA-1 targets Slug and endows lung cancer A549 cells with epithelial and anti-tumorigenic properties. Experimental Cell Research 2013 319 3 77 88 10.1016/j.yexcr.2012.10. 015
38. Hu Z., Chen X., Zhao Y., Tian T., Jin G., Shu Y., Chen Y., Xu L., Zen K., Zhang C., Shen H., Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. Journal of Clinical Oncology 2010 28 10 1721 1726 2-s2.0-77950498821 10.1200/JCO.2009.24.9342
39. Datta J., Kutay H., Nasser M. W., Nuovo G. J., Wang B., Majumder S., Liu C.-G., Volinia S., Croce C. M., Schmittgen T. D., Ghoshal K., Jacob S. T., Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Research 2008 68 13 5049 5058 2-s2.0-48549091046 10.1158/0008-5472.CAN-07-6655
40. Wei W., Hu Z., Fu H., Tie Y., Zhang H., Wu Y., Zheng X., MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Oncology Reports 2012 28 2 701 706
41. Li D., Yang P., Li H., MicroRNA-1 inhibits proliferation of hepatocarcinoma cells by targeting endothelin-1. Life Sciences 2012 91 11-12 440 447 10.1016/j.lfs.2012.08.015
42. Migliore C., Martin V., Leoni V. P., Restivo A., Atzori L., Petrelli A., Isella C., Zorcolo L., Sarotto I., Casula G., Comoglio P. M., Columbano A., Giordano S., miR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Clinical Cancer Research 2012 18 3 737 747 2-s2.0-84856510440 10.1158/1078-0432.CCR-11-1699
43. Sarver A. L., French A. J., Borralho P. M., Thayanithy V., Oberg A. L., Silverstein K. A. T., Morlan B. W., Riska S. M., Boardman L. A., Cunningham J. M., Subramanian S., Wang L., Smyrk T. C., Rodrigues C. M. P., Thibodeau S. N., Steer C. J., Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer 2009 9, article 401 2-s2.0-71549125896 10.1186/1471-2407-9-401
44. Reid J. F., Sokolova V., Zoni E., Lampis A., Pizzamiglio S., Bertan C., Zanutto S., Perrone F., Camerini T., Gallino G., Verderio P., Leo E., Pilotti S., Gariboldi M., Pierotti M. A., miRNA profiling in colorectal cancer highlights miR-1 involvement in MET-dependent proliferation. Molecular Cancer Research 2012 10 4 504 515 2-s2.0-84859809988 10.1158/1541-7786.MCR-11-0342
45. Chen W. S., Leung C. M., Pan H. W., Hu L. Y., Li S. C., Ho M. R., Tsai K. W., Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncology Reports 2012 28 3 1069 1076
46. Suzuki H., Takatsuka S., Akashi H., Yamamoto E., Nojima M., Maruyama R., Kai M., Yamano H.-O., Sasaki Y., Tokino T., Shinomura Y., Imai K., Toyota M., Genome-wide profiling of chromatin signatures reveals epigenetic regulation of microRNA genes in colorectal cancer. Cancer Research 2011 71 17 5646 5658 2-s2.0-80052195502 10.1158/0008-5472.CAN-11-1076
47. Kim C., Kim H. K., Rettig R. L., Kim J., Lee E. T., Aprelikova O., Choi I. J., Munroe D. J., Green J. E., miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Medical Genomics 2011 4, article 79 2-s2.0-81555234231 10.1186/1755-8794-4-79
48. Cooperberg M. R., Broering J. M., Carroll P. R., Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. Journal of the National Cancer Institute 2009 101 12 878 887 2-s2.0-67449126769 10.1093/jnci/djp122
49. Ambs S., Prueitt R. L., Yi M., Hudson R. S., Howe T. M., Petrocca F., Wallace T. A., Liu C.-G., Volinia S., Calin G. A., Yfantis H. G., Stephens R. M., Croce C. M., Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Research 2008 68 15 6162 6170 2-s2.0-51049123624 10.1158/0008-5472.CAN-08-0144
50. Kojima S., Chiyomaru T., Kawakami K., Yoshino H., Enokida H., Nohata N., Fuse M., Ichikawa T., Naya Y., Nakagawa M., Seki N., Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer. British Journal of Cancer 2012 106 2 405 413 2-s2.0-84856454111 10.1038/bjc.2011.462
51. Hudson R. S., Yi M., Esposito D., Watkins S. K., Hurwitz A. A., Yfantis H. G., Lee D. H., Borin J. F., Naslund M. J., Alexander R. B., Dorsey T. H., Stephens R. M., Croce C. M., Ambs S., MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Research 2012 40 8 3689 3703 2-s2.0-84860363146 10.1093/nar/gkr1222
52. Alshalalfa M., MicroRNA response elements-mediated miRNA-miRNA interactions in prostate cancer. Advances in Bioinformatics 2012 2012 10 839837 10.1155/2012/839837
53. Liu Y. N., Yin J. J., Abou-Kheir W., miR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 2013 32 3 296 306 10.1038/onc.2012.58
54. Al-Sukhun S., Hussain M., Current understanding of the Biology of advanced bladder cancer. Cancer 2003 97 8, supplement 2064 2075 2-s2.0-0037446050 (Pubitemid 36397247)
55. Pignot G., Cizeron-Clairac G., Vacher S., Microrna expression profile in a large series of bladder tumors: identification of a 3-mirna signature associated with aggressiveness of muscle-invasive bladder cancer. International Journal of Cancer 2013 132 11 2479 2491 10.1002/ijc.27949
56. Chiyomaru T., Enokida H., Kawakami K., Tatarano S., Uchida Y., Kawahara K., Nishiyama K., Seki N., Nakagawa M., Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urologic Oncology 2012 30 4 434 443 10.1016/j.urolonc.2010.05.008
57. Yoshino H., Chiyomaru T., Enokida H., Kawakami K., Tatarano S., Nishiyama K., Nohata N., Seki N., Nakagawa M., The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. British Journal of Cancer 2011 104 5 808 818 2-s2.0-79952280500 10.1038/bjc.2011.23
58. Yoshino H., Enokida H., Chiyomaru T., Tatarano S., Hidaka H., Yamasaki T., Gotannda T., Tachiwada T., Nohata N., Yamane T., Seki N., Nakagawa M., Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochemical and Biophysical Research Communications 2012 417 1 588 593 2-s2.0-84855773701 10.1016/j.bbrc.2011.12.011
59. Yamasaki T., Yoshino H., Enokida H., Hidaka H., Chiyomaru T., Nohata N., Kinoshita T., Fuse M., Seki N., Nakagawa M., Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. International Journal of Oncology 2012 40 6 1821 1830
60. Boring C. C., Squires T. S., Tong T., Cancer statistics, 1991. Boletin de la Asociacion Medica de Puerto Rico 1991 83 6 225 242 2-s2.0-0026177136
61. Childs G., Fazzari M., Kung G., Kawachi N., Brandwein-Gensler M., McLemore M., Chen Q., Burk R. D., Smith R. V., Prystowsky M. B., Belbin T. J., Schlecht N. F., Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. The American Journal of Pathology 2009 174 3 736 745 2-s2.0-62549120724 10.2353/ajpath.2009. 080731
62. Wang F., Song G., Liu M., Li X., Tang H., miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Letters 2011 585 20 3263 3269 2-s2.0-80054076679 10.1016/j.febslet.2011.08.052
63. Nohata N., Hanazawa T., Kikkawa N., Sakurai D., Sasaki K., Chiyomaru T., Kawakami K., Yoshino H., Enokida H., Nakagawa M., Okamoto Y., Seki N., Identification of novel molecular targets regulated by tumor suppressive miR-1/miR-133a in maxillary sinus squamous cell carcinoma. International Journal of Oncology 2011 39 5 1099 1107 2-s2.0-80053185730 10.3892/ijo.2011.1096
64. Wu C.-D., Kuo Y.-S., Wu H.-C., Lin C.-T., MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. Journal of Biomedical Science 2011 18 1, article 80 2-s2.0-80355132691 10.1186/1423-0127- 18-80
65. Nohata N., Sone Y., Hanazawa T., Fuse M., Kikkawa N., Yoshino H., Chiyomaru T., Kawakami K., Enokida H., Nakagawa M., Shozu M., Okamoto Y., Seki N., miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Oncotarget 2011 2 1-2 29 42 2-s2.0-79960856044
66. Leone V., D'Angelo D., Rubio I., De Freitas P. M., Federico A., Colamaio M., Pallante P., Medeiros-Neto G., Fusco A., miR-1 is a tumor suppressor in thyroid carcinogenesis targeting CCND2, CXCR4, and SDF-1 α Journal of Clinical Endocrinology and Metabolism 2011 96 9 E1388 E1398 2-s2.0-80052550487 10.1210/jc.2011-0345
67. Ferrari A., Dileo P., Casanova M., Bertulli R., Meazza C., Gandola L., Navarria P., Collini P., Gronchi A., Olmi P., Fossati-Bellani F., Casali P. G., Rhabdomyosarcoma in adults: a retrospective analysis of 171 patients treated at a single institution. Cancer 2003 98 3 571 580 2-s2.0-0037961997 10.1002/cncr.11550 (Pubitemid 36885998)
68. Miyachi M., Tsuchiya K., Yoshida H., Yagyu S., Kikuchi K., Misawa A., Iehara T., Hosoi H., Circulating muscle-specific microRNA, miR-206, as a potential diagnostic marker for rhabdomyosarcoma. Biochemical and Biophysical Research Communications 2010 400 1 89 93 2-s2.0-79951854611 10.1016/j.bbrc.2010. 08.015
69. Yan D., Dong X. D., Chen X., Wang L., Lu C., Wang J., Qu J., Tu L., MicroRNA-1/206 targets c-met and inhibits rhabdomyosarcoma development. The Journal of Biological Chemistry 2009 284 43 29596 29604 2-s2.0-70350383632 10.1074/jbc.M109.020511
70. Rao P. K., Missiaglia E., Shields L., Hyde G., Yuan B., Shepherd C. J., Shipley J., Lodish H. F., Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells. FASEB Journal 2010 24 9 3427 3437 2-s2.0-77956621053 10.1096/fj.09-150698
71. Taulli R., Bersani F., Foglizzo V., Linari A., Vigna E., Ladanyi M., Tuschl T., Ponzetto C., The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. Journal of Clinical Investigation 2009 119 8 2366 2378 2-s2.0-68849118992 10.1172/JCI38075
72. Li L., Sarver A. L., Alamgir S., Subramanian S., Downregulation of microRNAs miR-1, -206 and -29 stabilizes PAX3 and CCND2 expression in rhabdomyosarcoma. Laboratory Investigation 2012 92 4 571 583 2-s2.0-84859316621 10.1038/labinvest.2012.10
73. Duan Z., Shen J., Yang X., Prognostic significance of miRNA-1 (miR-1) expression in patients with chordoma. Journal of Orthopaedic Research 2014 32 5 695 701 10.1002/jor.22589
74. Namlos H. M., Meza-Zepeda L. A., Baroy T., Ostensen I. H., Kresse S. H., Kuijjer M. L., Serra M., Burger H., Cleton-Jansen A. M., Myklebost O., Modulation of the osteosarcoma expression phenotype by MicroRNAs. PLoS ONE 2012 7 10 e48086
75. Anton R., Chatterjee S. S., Simundza J., Cowin P., DasGupta R., A systematic screen for micro-RNAs regulating the canonical Wnt pathway. PLoS ONE 2011 6 10 2-s2.0-80054773989 10.1371/journal.pone.0026257 e26257
76. Karim R. Z., Tse G. M. K., Putti T. C., Scolyer R. A., Lee C. S., The significance of the Wnt pathway in the pathology of human cancers. Pathology 2004 36 2 120 128 2-s2.0-1942537708 10.1080/00313020410001671957 (Pubitemid 38507872)
77. Mishra P. J., Merlino G., MicroRNA reexpression as differentiation therapy in cancer. Journal of Clinical Investigation 2009 119 8 2119 2123 2-s2.0-68849083270 10.1172/JCI40107
78. Beltran A. S., Russo A., Lara H., Fan C., Lizardi P. M., Blancafort P., Suppression of breast tumor growth and metastasis by an engineered transcription factor. PLoS ONE 2011 6 9 2-s2.0-80052768726 10.1371/journal.pone.0024595 e24595
79. Tiemann K., Rossi J. J., RNAi-based therapeutics-current status, challenges and prospects. EMBO Molecular Medicine 2009 1 3 142 151 2-s2.0-77952043572 10.1002/emmm.200900023
80. Whitehead K. A., Langer R., Anderson D. G., Knocking down barriers: advances in siRNA delivery. Nature Reviews Drug Discovery 2009 8 2 129 138 2-s2.0-59349116903 10.1038/nrd2742
81. Ferber D., Gene therapy: safer and virus-free? Science 2001 294 5547 1638 1642 2-s2.0-0035941087 10.1126/science.294.5547.1638 (Pubitemid 33104814)
82. Waehler R., Russell S. J., Curiel D. T., Engineering targeted viral vectors for gene therapy. Nature Reviews Genetics 2007 8 8 573 587 2-s2.0-34447535345 10.1038/nrg2141 (Pubitemid 47077278)
83. Ghosh R., Singh L. C., Shohet J. M., Gunaratne P. H., A gold nanoparticle platform for the delivery of functional microRNAs into cancer cells. Biomaterials 2013 34 3 807 816 10.1016/j.biomaterials.2012.10.023